BRIEF-Eli Lilly Spokesperson Says No One Should Be Mass-Compounding Or Selling Knockoff Glp-1 Products Regardless Of How They’re Administered

Hims & Hers Health, Inc. Class A -7.88%
Eli Lilly and Company -2.26%

Hims & Hers Health, Inc. Class A

HIMS

23.84

-7.88%

Eli Lilly and Company

LLY

977.25

-2.26%

- Eli Lilly and Co LLY.N:

  • ELI LILLY SOKESPERSON: LOOK FORWARD TO DECISIVE STEPS FDA HAS ANNOUNCED IT WILL TAKE, AND WE URGE OTHER REGULATORS AND LAW ENFORCEMENT TO DO THE SAME

  • ELI LILLY SPOKESPERSON: NO ONE SHOULD BE MASS-COMPOUNDING OR SELLING KNOCKOFF GLP-1 PRODUCTS REGARDLESS OF HOW THEY’RE ADMINISTERED

Source text: [ID:]

Further company coverage: LLY.N


Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via